Cardiac Heart Failure Patients Clinical Trial
Official title:
Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure: the Coffee-it Study
To evaluate canrenone effects compared to other therapies on cardiovascular mortality in patients with congestive heart failure and preserved systolic function after 12 years of evaluation.
The investigators will verify patients with cardiac heart failure (CHF) and preserved
systolic function and each patient must have all clinical evaluation through basal
measurements of blood pressure, heart rate, biochemical tests, and color Doppler
echocardiographic parameters for at least 12 years.
The investigators will evaluate the effects of an aldosterone antagonist as canrenone
compared to a group without canrenone and the investogators will verify how many patients
reported cardiovascular mortality or will survive.
;